68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC

Clinical trial NCT06756217 · RECRUITING

Trial details

NCT number: NCT06756217
Sponsor: Ruijin Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Non-Small Cell Lung Cancer

Start date: 2024-12-30
Primary completion: 2026-06-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.